These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8356609)

  • 1. Production of interference in the TDx polarization immunoassay by fluorescein angiography.
    Rutzky LP; Amador A; Welsh M; Kahan BD
    Transplantation; 1993 Aug; 56(2):491-2. PubMed ID: 8356609
    [No Abstract]   [Full Text] [Related]  

  • 2. Convulsion following intravenous fluorescein angiography.
    Kelly SP; MacDermott NJ; Saunders DC; Leach FN
    Br J Ophthalmol; 1989 Aug; 73(8):655-6. PubMed ID: 2765447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: fluorescein as a circulation determinant.
    Toler SM
    Ann Pharmacother; 1995 Oct; 29(10):1052. PubMed ID: 8845553
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cyclosporine concentrations in renal transplant recipients using ACMIA and mFPIA methods.
    Kagawa Y; Yanagawa M; Muraki Y; Iwamoto T; Mizutani H; Sugimura Y; Kojima M
    Clin Biochem; 2004 Nov; 37(11):1016-21. PubMed ID: 15498531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the cost of phenytoin assays with in-house TDx reagents.
    Colbert DL; Turner GJ; Gooch JC
    Ann Clin Biochem; 1993 Nov; 30 ( Pt 6)():555-8. PubMed ID: 8304724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accidental intra-arterial injection of fluorescein dye.
    Bovino JA; Marcus DF
    Ophthalmic Surg; 1984 Dec; 15(12):983-4. PubMed ID: 6521981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study.
    Kwiterovich KA; Maguire MG; Murphy RP; Schachat AP; Bressler NM; Bressler SB; Fine SL
    Ophthalmology; 1991 Jul; 98(7):1139-42. PubMed ID: 1891225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A assays: comparison between radioimmunoassay and fluorescent polarization immunoassay technique by TDx, and the clinical significance of the polyclonal:monoclonal TDx ratio.
    McKenna BA; Pabico RC; Cerilli GJ
    Transplant Proc; 1994 Oct; 26(5):2818-9. PubMed ID: 7940886
    [No Abstract]   [Full Text] [Related]  

  • 9. Complications of intravenous fluorescein injections.
    Lipson BK; Yannuzzi LA
    Int Ophthalmol Clin; 1989; 29(3):200-5. PubMed ID: 2526795
    [No Abstract]   [Full Text] [Related]  

  • 10. Effective differences in the formulation of intravenous fluorescein and related side effects.
    Yannuzzi LA; Justice J; Baldwin HA
    Am J Ophthalmol; 1974 Aug; 78(2):217-21. PubMed ID: 4603199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of monitoring the efficacy of phenobarbital as an anticonvulsant agents using the fluorescence-polarization immunoassay].
    Karamehić J; Tulumović T; Uzeirbegović M; Trnovcević J; Asćerić M; Hadzibegić N
    Med Arh; 1998; 52(2):65-6. PubMed ID: 9769637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent venogram? an interesting side effect of fluorescein angiography.
    Kulshrestha MK; Goble R; Gibson J; Benson M
    Eye (Lond); 1996; 10 ( Pt 1)():146. PubMed ID: 8763327
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorescein interference in digoxin assay: an isolated case?
    Paterson JR; Weston R; Blackie R; Neithercut WD
    Ann Clin Biochem; 1991 May; 28 ( Pt 3)():314-5. PubMed ID: 1872583
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparative analysis of the immunochemical determination of gentamycin by fluorescence polarization and quenching].
    Gavrilov VB; Eremin SA; Egorov AM
    Antibiot Khimioter; 1992 Sep; 37(9):36-9. PubMed ID: 1444670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pulmonary edema following intravenous fluorescein angiography.
    Hess JB; Pacurariu RI
    Am J Ophthalmol; 1976 Oct; 82(4):567-70. PubMed ID: 970421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse reaction to intravenous fluorescein: evidence for sex difference.
    Greene GS; Bell LW; Hitching RA; Spaeth GL
    Ann Ophthalmol; 1976 May; 8(5):533-6. PubMed ID: 937936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical usefulness of cyclosporine therapeutic monitoring].
    Di Fede G; Iacò V; Pepe S; Salerno L
    Clin Ter; 1999; 150(5):339-42. PubMed ID: 10687263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions in intravenous fluorescein angiography.
    Butner RW; McPherson AR
    Ann Ophthalmol; 1983 Nov; 15(11):1084-6. PubMed ID: 6651146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in plasma ionized calcium levels during fluorescein angiography].
    Turetta F; de Stefani R; Milanesi A; Cannizzaro A; Padoan AM; de Giorgio P
    J Fr Ophtalmol; 1985; 8(12):785-8. PubMed ID: 3833889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of precision and accuracy of a fluorescence polarization immunoassay system after dilution of serum samples containing fluorescein dye.
    Toler SM; Porter WH; Chandler MH
    Ther Drug Monit; 1990 May; 12(3):300-2. PubMed ID: 2349618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.